Celescreen Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Angel
- Latest Deal Amount
- $35.7K
- Investors
- 1
Celescreen General Information
Description
Developer of alternative toxicology testing methods. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Primary Office
- 96 Bis Boulevard Raspail
- 75006 Paris
- France
Celescreen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 20-Aug-2019 | $35.7K | 000.00 | 00000 | Completed | Product Development |
| 2. Angel (individual) | 13-Apr-2017 | 000.00 | 000.00 | 00000 | Completed | Product Development |
| 1. Accelerator/Incubator | 11-Sep-2014 | Completed | Product Development |
Celescreen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Ordinary | 16,000 | $1.114790 | $2.68 | $2.68 | 1x | $2.68 | 29.09% |
Celescreen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 |